ADAR1 Capital Management »

Adlai Nortye Ltd Sponsored shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $816k 118k 6.92

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Adlai Nortye Ltd Sponsored

VR Adviser
Cormorant Asset Management
Squadron Capital Management
Balyasny Asset Management
Millennium Management
Casdin Capital
Woodline Partners
UBS Group
Ameriprise Financial
ADAR1 Capital Management
Toroso Investments
Cantor Fitzgerald, L. P.
TD Asset Management
Ikarian Capital
Persistent Asset Partners

View all funds holding Adlai Nortye Ltd Sponsored